Oncology Consulting

Specialised data and insights to commercialise oncology products, manage risks and improve patient outcomes.
Oncology Consulting Health Kantar
Benefits
01

Prioritise pipeline and investments

Get highly specialised guidance to evaluate product opportunities and pursue partnerships.
02

Reach more patients

Use evidence of your product’s safety, efficacy and value to achieve optimal pricing strategies and broad market access.
03

Accelerate launch and post-marketing activities

Build on existing knowledge as you progress through the product lifecycle, with connected insight across disciplines.

Get the right expertise, at the right time, for a winning market strategy.

R&D

We provide tumour-specific data and insights to help you prioritise your assets and optimise your portfolio.

Business Development and LicensingEpidemiologyForecastingHealth Economics and Outcomes ResearchKey Opinion Leader Identification and MappingPatient Insights

Subscription data: CancerMPact, Cancerology

Clinical trials

We provide connected clinical and real-world solutions to optimise clinical trials and prepare for you submission.

Phase II-IV trials, Market access & value definition, Medical writing, Non-Interventional StudiesPatient Reported Outcomes, Registries, Scientific Publications

Subscription data: CancerMPact, Cancerology

Submission & Approval

We generate evidence of your product's safety and effectiveness, so you can file with the confidence of a well-defined value proposition for all stakeholders.

Health Economics and Outcomes ResearchMarket access & value definitionRisk-Benefit Optimisation, Scientific Publications

Subscription data: Oncology Market Access

Launch

We offer consultative approaches to ensure the success of your launch, using connected commercial and real-world solutions.

Brand Strategy Forecasting Health Economics and Outcomes ResearchKOL Identification and Mapping, Market Understanding, Medical Writing, Patient & Physician Insights, Patient Preferences, Patient Reported OutcomesRisk Evaluation and Management

Subscription data: CancerMPact, Cancerology

Post Marketing

We use real-world evidence to expand access through new indications with demonstrated product safety and value.

Brand Optimisation, Health Economics and Outcomes Research, Medical Writing, Non-Interventional StudiesPatient Reported Outcomes, Patient Preferences, Registries, Risk Evaluation and Management

Subscription data: CancerMPact, Cancerology